Scaffolds, Stem Cells, and Tissues. Oh, My!
A primer for how the FDA regulates stem cells
A primer for how the FDA regulates stem cells
Johnny Franco, MD, FACS, discusses how implant removals, biologic innovation, and patient demand for long-term tissue health are accelerating a regenerative shift in body aesthetics.
The Series A funding will support the commercial expansion of a hydrogel template used in wound management and reconstructive surgery.